REVIVA PHARMACEUTICALS HOLDINGS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q3 2018 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Reviva Pharmaceuticals Holdings, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2018 to Q2 2024.
  • Reviva Pharmaceuticals Holdings, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 12, 2024 was 29.8M shares, a 31.6% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 29.8M +7.17M +31.6% Aug 12, 2024 10-Q 2024-08-14
Q1 2024 27.9M +7.47M +36.5% Mar 31, 2024 10-K 2024-04-15
Q3 2023 22.7M +2.21M +10.8% Nov 9, 2023 10-Q 2023-11-14
Q2 2023 22.7M +4.52M +24.9% Aug 11, 2023 10-Q 2023-08-14
Q1 2023 20.5M +5.32M +35.1% Mar 27, 2023 10-K 2023-03-30
Q3 2022 20.4M +6.46M +46.2% Nov 10, 2022 10-Q 2022-11-14
Q2 2022 18.1M +4.74M +35.4% Aug 12, 2022 10-Q 2022-08-15
Q1 2022 15.1M +5.9M +63.9% Mar 10, 2022 10-K 2022-03-15
Q3 2021 14M +8.86M +173% Nov 12, 2021 10-Q 2021-11-15
Q2 2021 13.4M +8.25M +161% Aug 12, 2021 10-Q 2021-08-16
Q1 2021 9.23M +1.56M +20.4% Mar 11, 2021 10-K/A 2021-05-07
Q4 2020 9.23M +967K +11.7% Jan 14, 2021 10-Q 2021-01-14
Q3 2020 5.12M -3.14M -38% Oct 14, 2020 10-Q 2020-10-14
Q2 2020 5.13M -3.13M -37.9% Jul 7, 2020 10-Q 2020-07-07
Q1 2020 7.67M May 1, 2020 10-K 2020-05-04
Q4 2019 8.27M 0 0% Jan 10, 2020 10-Q 2020-01-10
Q3 2019 8.27M 0 0% Oct 8, 2019 10-Q 2019-10-08
Q2 2019 8.27M Jul 3, 2019 10-Q 2019-07-03
Q4 2018 8.27M Jan 9, 2019 10-Q 2019-01-09
Q3 2018 8.27M Oct 11, 2018 10-Q 2018-10-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.